Ignite Creation Date:
2025-12-25 @ 12:39 AM
Ignite Modification Date:
2026-01-07 @ 3:57 AM
Study NCT ID:
NCT01825967
Status:
UNKNOWN
Last Update Posted:
2013-04-10
First Post:
2013-03-29
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Acute Diverticulitis and C-Reactive Protein as a Prognostic Marker
Sponsor:
Corporacion Parc Tauli
Organization:
Study Overview
Official Title:
Predictive Value of C-Reactive Protein in Acute Diverticulitis
Status:
UNKNOWN
Status Verified Date:
2013-04
Last Known Status:
NOT_YET_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The management of acute diverticulitis maybe better if we have prognostic markers of evolution.
Hypothesis: C-reactive protein maybe a good prognostic marker of evolution of acute diverticulitis.
The investigators need to know the values of C-reactive protein to predict evolution of acute diverticulitis.
Hypothesis: C-reactive protein maybe a good prognostic marker of evolution of acute diverticulitis.
The investigators need to know the values of C-reactive protein to predict evolution of acute diverticulitis.
Detailed Description:
A prospective observational study. All the patients with TC-diagnosis of acute diverticulitis (AD) had a C-reactive protein (PCR) in the initial blood test.
The investigators will predict evolution of AD with the PCR initial.
The investigators will predict evolution of AD with the PCR initial.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: